middle.news
Syntara Secures A$10 Million to Fuel Clinical Trials After FDA Nod
10:52am on Wednesday 29th of April, 2026 AEST
•
Healthcare
Read Story
Syntara Secures A$10 Million to Fuel Clinical Trials After FDA Nod
10:52am on Wednesday 29th of April, 2026 AEST
Key Points
A$8 million institutional placement with strong investor support
A$2 million share purchase plan for existing shareholders
Funds to support five clinical trial readouts in 2026
Preparation for Phase 2b myelofibrosis study and patent strengthening
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Syntara (ASX:SNT)
OPEN ARTICLE